XML 40 R30.htm IDEA: XBRL DOCUMENT v3.19.2
Revenue Recognition and Collaborative Arrangements (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Revenue Recognition and Collaborative Arrangements        
Total net revenue from GSK $ 64,107 $ 67,086 $ 119,290 $ 119,466
GSK        
Revenue Recognition and Collaborative Arrangements        
Total net revenue from GSK 64,107 67,086 119,290 119,466
GSK | Royalty revenue from a related party        
Revenue Recognition and Collaborative Arrangements        
Royalties from a related party 67,563 70,542 126,202 126,378
Less: amortization of capitalized fees paid to a related party (3,456) (3,456) (6,912) (6,912)
GSK | RELVAR/BREO        
Revenue Recognition and Collaborative Arrangements        
Royalties from a related party 47,086 57,515 89,826 103,675
GSK | ANORO        
Revenue Recognition and Collaborative Arrangements        
Royalties from a related party 10,635 10,656 19,205 19,380
GSK | TRELEGY        
Revenue Recognition and Collaborative Arrangements        
Royalties from a related party $ 9,842 $ 2,371 $ 17,171 $ 3,323